Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 20894-20895 [2017-09013]

Download as PDF 20894 Federal Register / Vol. 82, No. 85 / Thursday, May 4, 2017 / Notices EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of respondents Form name Number of responses per respondent Hours per response Total burden hours Primary care site patient characteristics survey .............................................. Workflow mapping preliminary interview ......................................................... Workflow mapping group interview .................................................................. Workflow mapping follow-up interview ............................................................ Patient interview .............................................................................................. Community agency interview ........................................................................... 9 72 90 72 90 45 1 1 1 1 1 1 1.5 0.5 1.5 0.5 0.5 1 13.5 36 135 36 45 45 Total .......................................................................................................... 387 n/a n/a 2,628 hours EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN Number of respondents Form name Total burden hours Primary care site organizational characteristics survey .................................. Primary care site patient characteristics survey .............................................. Workflow mapping preliminary interview ......................................................... Workflow mapping group interview .................................................................. Workflow mapping follow-up interview ............................................................ Patient interview .............................................................................................. Community agency interview ........................................................................... 9 9 72 90 72 90 45 13.5 13.5 36 135 36 45 45 Total .......................................................................................................... 387 n/a Average hourly wage rate * a$ 40.41 Total cost burden c 22.20 $ 545.54 545.54 1,454.76 5,455.35 1,454.76 1,045.35 999.00 n/a 11,500.30 a 40.41 a 40.41 a 40.41 a 40.41 b 23.23 * For hourly average wage rates, mean hourly wages from the Bureau of Labor Statistics (BLS) May 2015 national occupational employment wage estimates were used. https://www.bls.gov/oes/current/oes_nat.htm#00-0000. a Participants will include a mix of providers and front desk staff; therefore a blended rate for these tasks are used including Nurse ($33.55), Medical Assistant ($15.011), Front Desk Staff ($13.382), Program Director ($32.56), Pharmacist ($56.96), Physician ($91.60), Behavioral health provider ($22.03). b Based upon the mean wages for consumers (all occupations). c Based upon the mean wages for Social Workers. pmangrum on DSK3GDR082PROD with NOTICES Request for Comments In accordance with the Paperwork Reduction Act, comments on AHRQ’s information collection are requested with regard to any of the following: (a) Whether the proposed collection of information is necessary for the proper performance of AHRQ health care research and health care information dissemination functions, including whether the information will have practical utility; (b) the accuracy of AHRQ’s estimate of burden (including hours and costs) of the proposed collection(s) of information; (c) ways to enhance the quality, utility and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information upon the respondents, including the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and included in the Agency’s subsequent request for OMB approval of the proposed information collection. All 1 https://www.bls.gov/oes/current/oes319092.htm. 2 https://www.bls.gov/oes/current/oes434171.htm. VerDate Sep<11>2014 14:39 May 03, 2017 Jkt 241001 comments will become a matter of public record. Sharon B. Arnold, Acting Director. [FR Doc. 2017–08997 Filed 5–3–17; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcements (FOAs) GH16–006, Conducting Public Health Research in Kenya; GH17–004, Conducting Public Health Research Activities in Egypt; GH17–005, Conducting Public Health Research in China. Time and Date: 9:00 a.m.–2:00 p.m., EDT, May 24, 2017 (Closed). PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Conducting Public Health Research in Kenya’’, GH16–006; ‘‘Conducting Public Health Research Activities in Egypt’’, GH17–004; and ‘‘Conducting Public Health Research in China’’, GH17–005. Contact Person for More Information: Hylan Shoob, Scientific Review Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 Clifton Road NE., Mailstop D–69, Atlanta, Georgia 30033, Telephone: (404) 639–4796. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and E:\FR\FM\04MYN1.SGM 04MYN1 Federal Register / Vol. 82, No. 85 / Thursday, May 4, 2017 / Notices 20895 Prevention and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention Administration for Children and Families Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Submission for OMB Review; Comment Request [FR Doc. 2017–09013 Filed 5–3–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review pmangrum on DSK3GDR082PROD with NOTICES In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement, PS17–005, Strengthening HIV/AIDS Research in Kenya. Time and Date: 10:00 a.m.–5:00 p.m., EDT, May 24, 2017 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Strengthening HIV/AIDS Research in Kenya’’, PS17–005. Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30329, Telephone: (404) 718– 8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement, RFA–TS17–001, Identify and Characterize Potential Environmental Risk Factors for Amyotrophic Lateral Sclerosis (ALS). Time and Date: 8:00 a.m.–5:00 p.m., EDT, May 31, 2017 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Identify and Characterize Potential Environmental Risk Factors for ALS’’, RFA–TS–17–001. Contact Person for More Information: Oscar Tarrago, M.D., M.P.H., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F63, Atlanta, Georgia 30341–3724, Telephone: (770) 488–3492. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017–09015 Filed 5–3–17; 8:45 am] Title: Center for States Evaluation Ancillary Data Collection. OMB No.: New Collection. Description: The Evaluation of the Child Welfare Capacity Building Collaborative, Center for States is sponsored by the Children’s Bureau, Administration for Children and Families of the U.S. Department of Health and Human Services. The purpose of this evaluation is to respond to a set of cross-cutting evaluation questions posed by the Children’s Bureau. This new information collection is an ancillary part of a larger data collection effort being conducted for the evaluation of the Child Welfare Capacity Building Collaborative. Two groups of instruments for the larger evaluation have already been submitted, and requests for clearance have been submitted to the Office of Management and Budget (see Federal Register Volume 80, No. 211, November 2, 2015; Federal Register Volume 81, No. 41, March 2, 2016; Federal Register Volume 81, No. 111, June 9, 2016; Federal Register Volume 81, No. 186, September 26, 2016), with the first group of instruments approved on August 31, 2016. This notice details a group of instruments that are specific only to the Center for States. The instruments focus on (1) evaluating an innovative approach to engaging professionals in networking and professional development through virtual conferences, (2) understanding fidelity to and effectiveness of the Center for States’ Capacity Building Model, and (3) capturing consistent information during the updated annual assessment process focused on related contextual issues impacting potential service delivery such as implementation of new legislation. Respondents: Respondents of these data collection instruments will include child welfare agency staff and stakeholders who directly receive services. BILLING CODE 4163–18–P [FR Doc. 2017–09014 Filed 5–3–17; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 14:39 May 03, 2017 Jkt 241001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\FR\FM\04MYN1.SGM 04MYN1

Agencies

[Federal Register Volume 82, Number 85 (Thursday, May 4, 2017)]
[Notices]
[Pages 20894-20895]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-09013]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcements (FOAs) 
GH16-006, Conducting Public Health Research in Kenya; GH17-004, 
Conducting Public Health Research Activities in Egypt; GH17-005, 
Conducting Public Health Research in China.
    Time and Date: 9:00 a.m.-2:00 p.m., EDT, May 24, 2017 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Conducting Public Health Research in Kenya'', GH16-006; 
``Conducting Public Health Research Activities in Egypt'', GH17-004; 
and ``Conducting Public Health Research in China'', GH17-005.
    Contact Person for More Information: Hylan Shoob, Scientific Review 
Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 
Clifton Road NE., Mailstop D-69, Atlanta, Georgia 30033, Telephone: 
(404) 639-4796.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and

[[Page 20895]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-09013 Filed 5-3-17; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.